Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
By L. Kraehenbuehl, Chien-Huan Weng, S. Eghbali, J. Wolchok, T. Merghoub. Nature Reviews Clinical Oncology, 2021
689 citations recorded by the source corpus.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/72ad32bf38a594697891d6492c72a9e1682839c5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Oncology
Citations in the corpus
- Evolving therapeutic landscape of advanced hepatocellular carcinoma (2022, background): “Many immuno-oncology agents can target other immuneregulatory molecules, such as TIM3, LAG3, TIGIT, IDO1 and CD40 (ref.(84)).”